- The aim of this proposal is to characterize the biochemical properties of human chymase, a serine class proteolytic enzyme secreted from mast cells, and investigate its interactions with protease inhibitors termed serpins (serine protease inhibitors). Many homeostatic processes contributing to protection from injury and inflammation involve secretion of proteases from inflammatory cells, such as mast cells. Inhibition of proteases by other proteins (e.g., serpins), provides regulation so that proteolysis is limited to specific processes. Therefore, understanding proteases and their inhibitors is important to health and disease. Recent findings indicate that chymase has high and low pH forms with different catalytic and substrate recognition properties. These forms may be important to the function of chymase and will be further investigated. X-ray crystal structure determination, site-directed mutagenesis, and spectroscopic analyses will be employed to understand the unique structural features of chymase producing these forms. The interaction of chymase with heparin, a proteoglycan secreted from mast cells, also will be studied using the recombinant chymase. This interaction is considered to have a role in regulating catalytic properties of chymase secreted from mast cells. These investigations, it is hoped, will define the catalytic properties of chymase and factors effecting its physiological substrate specificity more completely. The mechanism by which serpins inhibit proteases remains unclear. The effect of pH on the interaction of chymase with two serpins differed in a manner which suggests that two different intermediate steps may be involved in regulating the rate of inhibition. Further analysis of these two interactions using rapid mixing, spectroscopy, solvent isotope effects, and in vitro mutagenesis of chymase and serpin, will be utilized to define the biochemical nature (chemical or conformational) of these steps. These studies are aimed at establishing a more comprehensive mechanism for inhibition of proteases by serpins. It is hoped that these studies will advance our understanding of two classes of molecules which are important to production and regulation of inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042931-06
Application #
2837549
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Moshell, Alan N
Project Start
1993-12-27
Project End
2002-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Dermatology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Plotnick, Michael I; Samakur, Madhurika; Wang, Zhi Mei et al. (2002) Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown. Biochemistry 41:334-42
Solivan, Suzanne; Selwood, Trevor; Wang, Zhe Mei et al. (2002) Evidence for diversity of substrate specificity among members of the chymase family of serine proteases. FEBS Lett 512:133-8
Lazaar, Aili L; Plotnick, Michael I; Kucich, Umberto et al. (2002) Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol 169:1014-20
Cooley, J; Takayama, T K; Shapiro, S D et al. (2001) The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40:15762-70
Estebanez-Perpina, E; Fuentes-Prior, P; Belorgey, D et al. (2000) Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol Chem 381:1203-14
Groutas, W C; Schechter, N M; He, S et al. (1999) Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. Bioorg Med Chem Lett 9:2199-204
Pereira, P J; Wang, Z M; Rubin, H et al. (1999) The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J Mol Biol 286:163-73
Selwood, T; McCaslin, D R; Schechter, N M (1998) Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure. Biochemistry 37:13174-83
Wang, Z; Walter, M; Selwood, T et al. (1998) Recombinant expression of human mast cell proteases chymase and tryptase. Biol Chem 379:167-74
Schechter, N M; Brass, L F; Lavker, R M et al. (1998) Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176:365-73

Showing the most recent 10 out of 19 publications